Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

May 4, 2026

Study Completion Date

May 4, 2027

Conditions
Breast CancerAromatase Inhibitors
Interventions
OTHER

Whole-body cryotherapy

"The term cryotherapy refers to the process of chilling the body for medicinal purposes. WBC is carried out in a dedicated temperature and humidity controlled cryogenic chamber, which includes a brief exposure to extremely cold air. To avoid frostbite, only a few layers of clothes will be worn during the exposure. To avoid skin burns and necrosis, each participant must first remove their sweat before entering the cryochamber and a surgical mask is also worn to prevent moist air from being exhaled. Subjects will move their fingers and legs in the cryochamber and avoid holding their breath. The exposure time will be 4 minutes and 30 seconds in -85°C."

OTHER

Placebo cryotherapy

The patient will be placed in a -85°C chamber for 1 minute as part of the placebo treatment.

Trial Locations (2)

30029

RECRUITING

CHU de Nîmes, Nîmes

34295

RECRUITING

CHU de Montpellier, Montpellier

All Listed Sponsors
collaborator

CryoMed Millenaire

UNKNOWN

lead

University Hospital, Montpellier

OTHER